Cargando…

Cost-Effectiveness of an Adjuvanted Hepatitis B Vaccine (HEPLISAV-B) in Patients With Inflammatory Bowel Disease

BACKGROUND: Compare the cost-effectiveness of 2 recombinant hepatitis B virus (HBV) vaccines in patients with inflammatory bowel disease (IBD). METHODS: Markov models were developed for 2 IBD cohorts: (1) 40-year-old patients prior to starting IBD treatment and (2) 40-year-old patients already recei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corral, Juan E, Kwon, Joshua Y, Caldera, Freddy, Pungpapong, Surakit, Spaulding, Aaron C, Borah, Bijan J, Moriarty, James P, Farraye, Francis A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Observations and Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802290/ https://www.ncbi.nlm.nih.gov/pubmed/36777070 http://dx.doi.org/10.1093/crocol/otaa090

Ejemplares similares

Efficacy of a two-dose hepatitis B vaccination with a novel immunostimulatory sequence adjuvant (Heplisav-B) on patients with chronic liver disease: a retrospective study
por: Kwon, Joshua Y., et al.
Publicado: (2023)

Transient Hepatitis B Surface Antigenemia Following Immunization with Heplisav-B
por: Corsini Campioli, Cristina, et al.
Publicado: (2021)

The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients With Inflammatory Bowel Disease Treated With Vedolizumab
por: Harrington, Jill E, et al.
Publicado: (2020)

Use of Standardized Inflammatory Bowel Disease Endoscopy Scores in Clinical Practice
por: Gaidos, Jill K J, et al.
Publicado: (2023)

21. Current and Nadir CD4+ Counts Are Associated with Heplisav-B Seroprotection Rates in People with HIV
por: Schnittman, Samuel, et al.
Publicado: (2020)

Accuracy of Self-Reported Vaccination Status in a Cohort of Patients with Inflammatory Bowel Disease
por: Smith, Ryan, et al.
Publicado: (2020)

Standardizing shared vaccination responsibilities among specialists to improve vaccination rates of immunosuppressed patients
por: Bhat, Shubha, et al.
Publicado: (2021)

Economic and Clinical Burden of Herpes Zoster Among Patients With Inflammatory Bowel Disease in the United States
por: Singer, David, et al.
Publicado: (2023)

Equivalent Cellular and Humoral Immunity to Varicella Zoster Virus in Patients With Inflammatory Bowel Disease and Healthy Older Adults for Whom Immunization Is Recommended
por: Caldera, Freddy, et al.
Publicado: (2022)

Reducing the Risk of Vaccine Preventable Diseases During the COVID-19 Pandemic
por: Lutz, Megan, et al.
Publicado: (2020)

Oral Contraceptive Pills Are an Effective Method of Preventing Pregnancy in Women With Crohn’s Disease
por: Daoud, Nader D, et al.
Publicado: (2021)

2287. Recently Approved HEPLISAV-B(R) [Hepatitis B Vaccine (Recombinant), Adjuvanted] Shows a Higher Proportion of Subjects Achieving Seroprotection With a More Consistent Immune Response Compared With Engerix-B(R) [Hepatitis B Vaccine (Recombinant)] in Three Comparative Trials
por: Hyer, Randall N, et al.
Publicado: (2018)

Time to Flexible Sigmoidoscopy or Colonoscopy in Patients Admitted With Ulcerative Colitis Has Decreased From 2012 to 2018
por: Bali, Aman S, et al.
Publicado: (2021)

What Gastroenterologists Should Know About COVID-19 Vaccines
por: Rolak, Stacey, et al.
Publicado: (2021)

Role of MUC5B during Group B Streptococcal Vaginal Colonization
por: Burcham, Lindsey R., et al.
Publicado: (2022)

Ethnic Variation Trends in the Use of Ileal Pouch–Anal Anastomosis in Patients With Ulcerative Colitis
por: Hashash, Jana G, et al.
Publicado: (2023)

Opioid Use Associated With Higher Costs Among Patients With Inflammatory Bowel Disease
por: Szigethy, Eva M, et al.
Publicado: (2021)

Salmonella Genomic Island 1B Variant Found in a Sequence Type 117 Avian Pathogenic Escherichia coli Isolate
por: Cummins, Max Laurence, et al.
Publicado: (2019)

Su1489: HUMORAL IMMUNOGENICITY OF THREE SARS-COV-2 MRNA VACCINE DOSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Schell, Trevor, et al.
Publicado: (2022)

Structural Basis for DNA Recognition by the Two-Component Response Regulator RcsB
por: Filippova, Ekaterina V., et al.
Publicado: (2018)

The impact of nutritional immunity on Group B streptococcal pathogenesis during wound infection
por: Akbari, Madeline S., et al.
Publicado: (2023)

Cost-Effectiveness of Proton Beam Therapy for Intraocular Melanoma
por: Moriarty, James P., et al.
Publicado: (2015)

Persistence With Biologic Therapy and Associated Costs of Patients With Inflammatory Bowel Disease: A German Retrospective Claims Data Analysis
por: Mahlich, Joerg, et al.
Publicado: (2021)

Association between smoking cessation and post-hospitalization healthcare costs: a matched cohort analysis
por: Nolan, Margaret B., et al.
Publicado: (2019)

Global Annotation, Expression Analysis, and Stability of Candidate sRNAs in Group B Streptococcus
por: Keogh, Rebecca A., et al.
Publicado: (2021)

Novel macrolide-lincosamide-streptogramin B resistance gene erm(56) in Trueperella pyogenes
por: Marchionatti, Emma, et al.
Publicado: (2023)

Diversity and Standard Nomenclature of Staphylococcus aureus Hyaluronate Lyases HysA and HysB
por: Hisatsune, Junzo, et al.
Publicado: (2023)

Effects of electroacupuncture on bladder and bowel function in patients with transverse myelitis: a prospective observational study
por: Wu, Jiani, et al.
Publicado: (2018)

Mammalian Endothermy Optimally Restricts Fungi and Metabolic Costs
por: Bergman, Aviv, et al.
Publicado: (2010)

Human Immunodeficiency Virus Tat Protein Aids V Region Somatic Hypermutation in Human B Cells
por: Wang, Xiaohua, et al.
Publicado: (2018)

The Type a and Type b Polysaccharide Capsules Predominate in an International Collection of Invasive Kingella kingae Isolates
por: Porsch, Eric A., et al.
Publicado: (2017)

Characterization of Amino Acid Substitution W20S in MgrB Involved in Polymyxin Resistance in Klebsiella pneumoniae
por: Roch, Mélanie, et al.
Publicado: (2022)

COVID-19 vaccination in adults with inflammatory bowel disease
por: Lutz, Megan, et al.
Publicado: (2023)

High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens
por: Counoupas, Claudio, et al.
Publicado: (2022)

Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United States
por: Dempsey, Timothy M., et al.
Publicado: (2022)

The Pseudomonas aeruginosa Exopolysaccharide Psl Facilitates Surface Adherence and NF-κB Activation in A549 Cells
por: Byrd, Matthew S., et al.
Publicado: (2010)

Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication
por: Adams, Lily E., et al.
Publicado: (2021)

Pairing Colicins B and E5 with Bdellovibrio bacteriovorus To Eradicate Carbapenem- and Colistin-Resistant Strains of Escherichia coli
por: Upatissa, Sumudu, et al.
Publicado: (2023)

Natural Transmission of Helicobacter saguini Causes Multigenerational Inflammatory Bowel Disease in C57/129 IL-10(−/−) Mice
por: Mannion, Anthony, et al.
Publicado: (2020)

Is Vedolizumab Truly Gut Selective? It May Not Affect the Immunogenicity of Vaccines in Patients With Inflammatory Bowel Disease
por: Lee, Alexander S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tk28mr016h9g0ka3n2jg8iv0hs